Bioprocessing of bacteriophages via rapid drying onto microcrystals

Barry Moore, Eva Alvarez-Gonzalez, Munerah Alfadhel, Parag Mane, Steven J. Ford, Christopher F. van der Walle

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation of an aqueous mixture of phage (Siphoviridae) and a crystallizable carrier (glutamine or glycine) in excess of water miscible organic solvent (isopropanol or isobutanol). The resultant suspension of phage-coated microcrystals can be harvested by filtration and the residual solvent removed rapidly by air-drying at a relative humidity of 75%. Albumin or trehalose added at 5% w/w of the crystalline carrier provide for better stabilization of the phage during co-precipitation. Free-flowing dry powders generated from an aqueous solution of phage (similar to 13 log10 pfu/mL) can be reconstituted in the same aqueous volume to a phage titer of almost 10 log10 pfu/mL; high enough to permit subsequent formulation steps following bioprocessing. The phage-coated microcrystals remain partially stable at room temperature for at least one month, which compares favorably with phage immobilized into polyester microcarriers or lyophilized with excipient (15% polyethylene glycol 6000 or 0.10.5 M sucrose). We anticipate that this bioprocessing technique will have application to other phage families as required for the development of phage therapies. (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012

LanguageEnglish
Pages540-548
Number of pages9
JournalBiotechnology Progress
Volume28
Issue number2
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Bacteriophages
Siphoviridae
Trehalose
Temperature
Polyesters
2-Propanol
Excipients
Humidity
Glutamine
Powders
Glycine
Sucrose
Albumins
Suspensions
Air
Water

Keywords

  • bacteriophages
  • immobilization
  • Staphylococcus aureus
  • bioprocessing
  • protein-coated microcrystals

Cite this

Moore, B., Alvarez-Gonzalez, E., Alfadhel, M., Mane, P., Ford, S. J., & van der Walle, C. F. (2012). Bioprocessing of bacteriophages via rapid drying onto microcrystals. Biotechnology Progress, 28(2), 540-548. https://doi.org/10.1002/btpr.740
Moore, Barry ; Alvarez-Gonzalez, Eva ; Alfadhel, Munerah ; Mane, Parag ; Ford, Steven J. ; van der Walle, Christopher F. / Bioprocessing of bacteriophages via rapid drying onto microcrystals. In: Biotechnology Progress. 2012 ; Vol. 28, No. 2. pp. 540-548.
@article{b3db4a0d45bd46fda363a00a422d586c,
title = "Bioprocessing of bacteriophages via rapid drying onto microcrystals",
abstract = "We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation of an aqueous mixture of phage (Siphoviridae) and a crystallizable carrier (glutamine or glycine) in excess of water miscible organic solvent (isopropanol or isobutanol). The resultant suspension of phage-coated microcrystals can be harvested by filtration and the residual solvent removed rapidly by air-drying at a relative humidity of 75{\%}. Albumin or trehalose added at 5{\%} w/w of the crystalline carrier provide for better stabilization of the phage during co-precipitation. Free-flowing dry powders generated from an aqueous solution of phage (similar to 13 log10 pfu/mL) can be reconstituted in the same aqueous volume to a phage titer of almost 10 log10 pfu/mL; high enough to permit subsequent formulation steps following bioprocessing. The phage-coated microcrystals remain partially stable at room temperature for at least one month, which compares favorably with phage immobilized into polyester microcarriers or lyophilized with excipient (15{\%} polyethylene glycol 6000 or 0.10.5 M sucrose). We anticipate that this bioprocessing technique will have application to other phage families as required for the development of phage therapies. (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012",
keywords = "bacteriophages, immobilization, Staphylococcus aureus, bioprocessing, protein-coated microcrystals",
author = "Barry Moore and Eva Alvarez-Gonzalez and Munerah Alfadhel and Parag Mane and Ford, {Steven J.} and {van der Walle}, {Christopher F.}",
note = "Copyright {\circledC} 2011 American Institute of Chemical Engineers (AIChE).",
year = "2012",
month = "4",
doi = "10.1002/btpr.740",
language = "English",
volume = "28",
pages = "540--548",
journal = "Biotechnology Progress",
issn = "8756-7938",
number = "2",

}

Moore, B, Alvarez-Gonzalez, E, Alfadhel, M, Mane, P, Ford, SJ & van der Walle, CF 2012, 'Bioprocessing of bacteriophages via rapid drying onto microcrystals' Biotechnology Progress, vol. 28, no. 2, pp. 540-548. https://doi.org/10.1002/btpr.740

Bioprocessing of bacteriophages via rapid drying onto microcrystals. / Moore, Barry; Alvarez-Gonzalez, Eva; Alfadhel, Munerah; Mane, Parag; Ford, Steven J.; van der Walle, Christopher F.

In: Biotechnology Progress, Vol. 28, No. 2, 04.2012, p. 540-548.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bioprocessing of bacteriophages via rapid drying onto microcrystals

AU - Moore, Barry

AU - Alvarez-Gonzalez, Eva

AU - Alfadhel, Munerah

AU - Mane, Parag

AU - Ford, Steven J.

AU - van der Walle, Christopher F.

N1 - Copyright © 2011 American Institute of Chemical Engineers (AIChE).

PY - 2012/4

Y1 - 2012/4

N2 - We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation of an aqueous mixture of phage (Siphoviridae) and a crystallizable carrier (glutamine or glycine) in excess of water miscible organic solvent (isopropanol or isobutanol). The resultant suspension of phage-coated microcrystals can be harvested by filtration and the residual solvent removed rapidly by air-drying at a relative humidity of 75%. Albumin or trehalose added at 5% w/w of the crystalline carrier provide for better stabilization of the phage during co-precipitation. Free-flowing dry powders generated from an aqueous solution of phage (similar to 13 log10 pfu/mL) can be reconstituted in the same aqueous volume to a phage titer of almost 10 log10 pfu/mL; high enough to permit subsequent formulation steps following bioprocessing. The phage-coated microcrystals remain partially stable at room temperature for at least one month, which compares favorably with phage immobilized into polyester microcarriers or lyophilized with excipient (15% polyethylene glycol 6000 or 0.10.5 M sucrose). We anticipate that this bioprocessing technique will have application to other phage families as required for the development of phage therapies. (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012

AB - We present an alternative bioprocess for bacteriophages involving room temperature coprecipitation of an aqueous mixture of phage (Siphoviridae) and a crystallizable carrier (glutamine or glycine) in excess of water miscible organic solvent (isopropanol or isobutanol). The resultant suspension of phage-coated microcrystals can be harvested by filtration and the residual solvent removed rapidly by air-drying at a relative humidity of 75%. Albumin or trehalose added at 5% w/w of the crystalline carrier provide for better stabilization of the phage during co-precipitation. Free-flowing dry powders generated from an aqueous solution of phage (similar to 13 log10 pfu/mL) can be reconstituted in the same aqueous volume to a phage titer of almost 10 log10 pfu/mL; high enough to permit subsequent formulation steps following bioprocessing. The phage-coated microcrystals remain partially stable at room temperature for at least one month, which compares favorably with phage immobilized into polyester microcarriers or lyophilized with excipient (15% polyethylene glycol 6000 or 0.10.5 M sucrose). We anticipate that this bioprocessing technique will have application to other phage families as required for the development of phage therapies. (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012

KW - bacteriophages

KW - immobilization

KW - Staphylococcus aureus

KW - bioprocessing

KW - protein-coated microcrystals

U2 - 10.1002/btpr.740

DO - 10.1002/btpr.740

M3 - Article

VL - 28

SP - 540

EP - 548

JO - Biotechnology Progress

T2 - Biotechnology Progress

JF - Biotechnology Progress

SN - 8756-7938

IS - 2

ER -